Skip to main content
Log in

A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II)

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Coit D, Ariyan C. MelMART Trial: it’s now or never. Ann Surg Oncol. 2018;25(9):2493–5.

    Article  Google Scholar 

  2. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.

    Article  CAS  Google Scholar 

  3. Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(3):422–9.

    Article  CAS  Google Scholar 

  4. Swetter SM, Thompson JA, Albertini MR, et al. NCCN® Guidelines Insights: Melanoma: Cutaneous, Version 2.2021: Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw. 2021;19(4):364–76.

    Article  Google Scholar 

  5. Moncrieff MD, Gyorki D, Saw R, et al. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Ann Surg Oncol. 2018;25(9):2541–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Michael C. Lowe MD.

Ethics declarations

DISCLOSURE

The authors declare they have no conflicts of interest and nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 175 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossi, A.J., Verbus, E.A., Faries, M.B. et al. A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II). Ann Surg Oncol 29, 4050–4051 (2022). https://doi.org/10.1245/s10434-022-11766-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11766-z

Navigation